InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (59 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
59
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Mathew Aby J., Executive Vice President and Chief Scientific Officer. Director active across 1 company, notably Biolife Solutions INC. Aggregated, 107 reports have been published. Split: 0 buy · 59 sells. Total volume traded: €1.4m. History available since 17 May 2021. The latest transaction was disclosed on 7 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mathew Aby J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations107 total
516 shares@ US$27.790.0010% mcap0.7% of flowCommon StockSEC:0001628280-26-048053:0
564 sharesCommon StockSEC:0001628280-26-044694:0
627 sharesCommon StockSEC:0001628280-26-042284:0
515 shares@ US$19.270.4% of flowCommon StockSEC:0001628280-26-024767:0
2,255 shares@ US$19.122.1% of flowCommon StockSEC:0001628280-26-020574:0
529 shares@ US$20.740.5% of flowCommon StockSEC:0001628280-26-015340:0
20,096 sharesCommon StockSEC:0001628280-26-012473:0
405 shares@ US$25.590.5% of flowCommon StockSEC:0001628280-26-001383:0
631 shares@ US$25.130.8% of flowCommon StockSEC:0001628280-25-057724:0
526 shares@ US$26.740.7% of flowCommon StockSEC:0001628280-25-054278:0
509 shares@ US$27.360.6% of flowCommon StockSEC:0001628280-25-045017:0
630 shares@ US$26.830.8% of flowCommon StockSEC:0001556355-25-000003:0
531 shares@ US$25.440.7% of flowCommon StockSEC:0001628280-25-041304:0
536 shares@ US$22.270.6% of flowCommon StockSEC:0001628280-25-034682:0
637 shares@ US$23.700.8% of flowCommon StockSEC:0001628280-25-031102:0
521 shares@ US$22.460.5% of flowCommon StockSEC:0001628280-25-028700:0
569 shares@ US$20.110.5% of flowCommon StockSEC:0001628280-25-017588:0
10,589 shares@ US$22.6611.1% of flowCommon StockSEC:0001628280-25-016633:0
22,919 sharesCommon StockSEC:0001628280-25-014184:0
1,597 shares@ US$25.001.8% of flowCommon StockSEC:0001628280-25-012679:0
425 shares@ US$25.460.5% of flowCommon StockSEC:0001628280-25-010565:0
92 shares@ US$26.540.1% of flowCommon StockSEC:0001628280-25-005844:0
404 shares@ US$27.020.5% of flowCommon StockSEC:0001628280-25-000986:0
7,604 shares@ US$27.339.9% of flowCommon StockSEC:0001628280-24-052104:0
523 shares@ US$27.200.7% of flowCommon StockSEC:0001628280-24-049479:0
25 of 107 declarations
About Mathew Aby J.
Mathew Aby J. is Executive Vice President and Chief Scientific Officer at Biolife Solutions INC (XNAS). He has 106 filings in total, and across the sampled filings from 2021-05-19 to 2026-06-22, the transactions are sales for EUR 1,429,847 and no purchases.
